Your browser doesn't support javascript.
loading
Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.
Jeffries, Lauren; Mis, Emily K; McWalter, Kirsty; Donkervoort, Sandra; Brodsky, Nina N; Carpier, Jean-Marie; Ji, Weizhen; Ionita, Cristian; Roy, Bhaskar; Morrow, Jon S; Darbinyan, Armine; Iyer, Krishna; Aul, Ritu B; Banka, Siddharth; Chao, Katherine R; Cobbold, Laura; Cohen, Stacey; Custodio, Helena M; Drummond-Borg, Margaret; Elmslie, Frances; Finanger, Erika; Hainline, Bryan E; Helbig, Ingo; Hewson, Stacy; Hu, Ying; Jackson, Adam; Josifova, Dragana; Konstantino, Monica; Leach, Meganne E; Mak, Bryan; McCormick, David; McGee, Elisabeth; Nelson, Stanley; Nguyen, Joanne; Nugent, Kimberly; Ortega, Lucy; Goodkin, Howard P; Roeder, Elizabeth; Roy, Sani; Sapp, Katie; Saade, Dimah; Sisodiya, Sanjay M; Stals, Karen; Towner, Shelley; Wilson, William; Khokha, Mustafa K; Bönnemann, Carsten G; Lucas, Carrie L; Lakhani, Saquib A.
Affiliation
  • Jeffries L; Yale University School of Medicine, Department of Pediatrics, New Haven, CT; Yale Pediatric Genomics Discovery Program, New Haven, CT.
  • Mis EK; Yale University School of Medicine, Department of Pediatrics, New Haven, CT; Yale Pediatric Genomics Discovery Program, New Haven, CT.
  • McWalter K; GeneDx, Gaithersburg, MD.
  • Donkervoort S; Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
  • Brodsky NN; Yale University School of Medicine, Department of Pediatrics, New Haven, CT; Yale Pediatric Genomics Discovery Program, New Haven, CT; Yale University School of Medicine, Department of Immunobiology, New Haven, CT.
  • Carpier JM; Yale University School of Medicine, Department of Immunobiology, New Haven, CT.
  • Ji W; Yale University School of Medicine, Department of Pediatrics, New Haven, CT; Yale Pediatric Genomics Discovery Program, New Haven, CT.
  • Ionita C; Yale University School of Medicine, Department of Pediatrics, New Haven, CT.
  • Roy B; Yale University School of Medicine, Department of Neurology, New Haven, CT.
  • Morrow JS; Yale University School of Medicine, Department of Pathology, New Haven, CT.
  • Darbinyan A; Yale University School of Medicine, Department of Pathology, New Haven, CT.
  • Iyer K; Yale University School of Medicine, Department of Pathology, New Haven, CT.
  • Aul RB; Hospital for Sick Children, Division of Clinical and Metabolic Genetics, Toronto, Ontario, Canada.
  • Banka S; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, United Kingdom; Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manch
  • Chao KR; Center for Mendelian Genomics, Broad Institute of MIT and Harvard, Cambridge, MA.
  • Cobbold L; South West Thames Regional Genetics Service, St George's, University of London, London, United Kingdom.
  • Cohen S; Children's Hospital of Philadelphia, Division of Neurology, Philadelphia, PA; The Epilepsy NeuroGenetics Initiative (ENGIN), Children's Hospital of Philadelphia, Philadelphia, PA; University of Pennsylvania Perelman School of Medicine, Department of Neurology, Philadelphia, PA.
  • Custodio HM; Department of Clinical and Experimental Epilepsy, University College London Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom; Chalfont Centre for Epilepsy, Buckinghamshire, United Kingdom.
  • Drummond-Borg M; Cook Children's Medical Center, Division of Genetics, Fort Worth, TX.
  • Elmslie F; South West Thames Regional Genetics Service, St George's, University of London, London, United Kingdom.
  • Finanger E; Oregon Health & Science University, Portland, OR.
  • Hainline BE; Indiana University School of Medicine, Indiana University Health Physicians, Indianapolis, IN.
  • Helbig I; Children's Hospital of Philadelphia, Division of Neurology, Philadelphia, PA; University of Pennsylvania Perelman School of Medicine, Department of Neurology, Philadelphia, PA.
  • Hewson S; Hospital for Sick Children, Division of Clinical and Metabolic Genetics, Toronto, Ontario, Canada.
  • Hu Y; Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
  • Jackson A; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, United Kingdom; Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manch
  • Josifova D; Guys and St Thomas NHS Trust, Clinical Genetics, London, United Kingdom.
  • Konstantino M; Yale Pediatric Genomics Discovery Program, New Haven, CT.
  • Leach ME; Oregon Health & Science University, Portland, OR.
  • Mak B; University of California Los Angeles, David Geffen School of Medicine, Department of Human Genetics, Los Angeles, CA; Current affiliation: Genome Medical, South San Francisco, CA.
  • McCormick D; King's College Hospital, Paediatric Neurosciences, London, United Kingdom.
  • McGee E; University of California Los Angeles, David Geffen School of Medicine, Department of Human Genetics, Los Angeles, CA; University of California Los Angeles, Clinical Genomics Center, Los Angeles, CA; University of California Los Angeles, Center for Duchenne Muscular Dystrophy, Los Angeles, CA.
  • Nelson S; University of California Los Angeles, David Geffen School of Medicine, Department of Human Genetics, Los Angeles, CA; University of California Los Angeles, Clinical Genomics Center, Los Angeles, CA; University of California Los Angeles, Center for Duchenne Muscular Dystrophy, Los Angeles, CA.
  • Nguyen J; Cook Children's Medical Center, Division of Genetics, Fort Worth, TX.
  • Nugent K; Baylor College of Medicine, Department of Pediatrics, Houston, TX; Baylor College of Medicine, Department of Molecular and Human Genetics, Houston, TX; Current affiliation: Cooper Surgical, Trumbull, CT.
  • Ortega L; Cook Children's Medical Center, Division of Genetics, Fort Worth, TX.
  • Goodkin HP; University of Virginia School of Medicine, Charlottesville, VA.
  • Roeder E; Baylor College of Medicine, Department of Pediatrics, Houston, TX; Baylor College of Medicine, Department of Molecular and Human Genetics, Houston, TX.
  • Roy S; Cook Children's Medical Center, Division of Endocrinology and Diabetes, Fort Worth, TX.
  • Sapp K; Indiana University School of Medicine, Indiana University Health Physicians, Indianapolis, IN.
  • Saade D; Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; Current affiliation: University of Iowa Carver College of Medicine, Iowa City, IA.
  • Sisodiya SM; Department of Clinical and Experimental Epilepsy, University College London Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom; Chalfont Centre for Epilepsy, Buckinghamshire, United Kingdom.
  • Stals K; Royal Devon & Exeter NHS Foundation Trust, Exeter Genomics Laboratory, Exeter, United Kingdom.
  • Towner S; University of Virginia School of Medicine, Charlottesville, VA.
  • Wilson W; University of Virginia School of Medicine, Charlottesville, VA.
  • Khokha MK; Yale University School of Medicine, Department of Pediatrics, New Haven, CT; Yale Pediatric Genomics Discovery Program, New Haven, CT; Yale University School of Medicine, Department of Genetics, New Haven, CT.
  • Bönnemann CG; Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
  • Lucas CL; Yale Pediatric Genomics Discovery Program, New Haven, CT; Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
  • Lakhani SA; Yale University School of Medicine, Department of Pediatrics, New Haven, CT; Yale Pediatric Genomics Discovery Program, New Haven, CT. Electronic address: saquib.lakhani@yale.edu.
Genet Med ; 26(2): 101023, 2024 Feb.
Article in En | MEDLINE | ID: mdl-37947183
ABSTRACT

PURPOSE:

We sought to delineate a multisystem disorder caused by recessive cysteine-rich with epidermal growth factor-like domains 1 (CRELD1) gene variants.

METHODS:

The impact of CRELD1 variants was characterized through an international collaboration utilizing next-generation DNA sequencing, gene knockdown, and protein overexpression in Xenopus tropicalis, and in vitro analysis of patient immune cells.

RESULTS:

Biallelic variants in CRELD1 were found in 18 participants from 14 families. Affected individuals displayed an array of phenotypes involving developmental delay, early-onset epilepsy, and hypotonia, with about half demonstrating cardiac arrhythmias and some experiencing recurrent infections. Most harbored a frameshift in trans with a missense allele, with 1 recurrent variant, p.(Cys192Tyr), identified in 10 families. X tropicalis tadpoles with creld1 knockdown displayed developmental defects along with increased susceptibility to induced seizures compared with controls. Additionally, human CRELD1 harboring missense variants from affected individuals had reduced protein function, indicated by a diminished ability to induce craniofacial defects when overexpressed in X tropicalis. Finally, baseline analyses of peripheral blood mononuclear cells showed similar proportions of immune cell subtypes in patients compared with healthy donors.

CONCLUSION:

This patient cohort, combined with experimental data, provide evidence of a multisystem clinical syndrome mediated by recessive variants in CRELD1.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Neurodevelopmental Disorders / Reinfection Limits: Humans Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Neurodevelopmental Disorders / Reinfection Limits: Humans Language: En Year: 2024 Type: Article